Back to search
FDAFDA · Food and drugs·Recall number D-0047-2024

Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771 USA, NDC 66689-305-16

Published October 25, 2023 · Recall initiated: October 18, 2023

Summary

FDA records drug Class I recall D-0047-2024, published October 25, 2023 and initiated October 18, 2023. Recalling firm: VistaPharm LLC; Status: Terminated; Reported quantity: 180 bottles; Lot: Lot#: 810300, Exp 10/2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.

What to do

Voluntary: Firm initiated · Letter

Get an email if SUCRALFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SUCRALFATE
Manufacturer
VistaPharm LLC
Distributor
USA Nationwide
UPC
0366689305165
Lot
Lot#: 810300, Exp 10/2023
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771 USA, NDC 66689-305-16 recalled?

Yes. FDA published recall D-0047-2024 on October 25, 2023. Reported hazard: Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SUCRALFATE. UPC: 0366689305165.